Plasma levels of MASP-1, MASP-3 and MAp44 in patients with type 2 diabetes: influence of glycaemic control, body composition and polymorphisms in the MASP1 gene
- 20 April 2017
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 189 (1) , 103-112
Abstract
Mounting evidence indicates that adverse activation of the complement system plays a role in the development of diabetic vascular complications. Plasma levels of the complement proteins mannan-binding lectin (MBL) and its associated serine proteases (MASP-1 and MASP-2) are elevated in diabetes. We hypothesized that single nucleotide polymorphisms (SNPs) in the MASP1 gene may contribute to altered plasma levels of the belonging gene products; MASP-1, MASP-3 and mannan-binding lectin-associated protein of 44 kDa (MAp44) in patients with type 2 diabetes. To investigate this, we compared plasma levels of MASP-1, MASP-3 and MAp44 in 100 patients with type 2 diabetes and 100 sex- and age-matched controls. Ten carefully selected SNPs were analysed using TaqMan® genotyping assay. Additionally, we included a streptozotocin-induced diabetes mouse model to directly examine the effect of inducing diabetes on MASP-1 levels. MASP-1 levels were significantly higher among patients with type 2 diabetes compared with healthy controls (P = 0·017). Five SNPs (rs874603, rs72549254, rs3774275, rs67143992, rs850312) in the MASP1 gene were associated with plasma levels of MASP-1, MASP-3 and MAp44. In the diabetes mouse model, diabetic mice had significantly higher MASP-1 levels than control mice (P = 0·003). In conclusion, MASP-1 levels were higher among patients with type 2 diabetes and diabetic mice. The mechanism behind this increase remains elusive.Keywords
This publication has 31 references indexed in Scilit:
- Plasma levels of mannan-binding lectin-associated serine proteases MASP-1 and MASP-2 are elevated in type 1 diabetes and correlate with glycaemic controlClinical and Experimental Immunology, 2015
- Multiple roles of complement MASP-1 at the interface of innate immune response and coagulationMolecular Immunology, 2014
- Diabetes‐induced Changes in Mannan‐binding Lectin Levels and Complement Activation in a Mouse Model of Type 1 DiabetesScandinavian Journal of Immunology, 2013
- The Effect of Weight Loss on Serum Mannose-Binding Lectin LevelsJournal of Immunology Research, 2012
- Binding of mannose‐binding lectin to fructosamines: a potential link between hyperglycaemia and complement activation in diabetesDiabetes/Metabolism Research and Reviews, 2010
- Complement activation and diabetic vascular complicationsClinica Chimica Acta, 2005
- Association Between Mannose-Binding Lectin and Vascular Complications in Type 1 DiabetesDiabetes, 2004
- Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organProceedings of the Nutrition Society, 2001
- Localization of the genes for the 100-kDa complement-activating components of Ra-reactive factor (CRARF and Crarf) to human 3q27–q28 and mouse 16B2–B3Genomics, 1995
- Europium as a label in time-resolved immunofluorometric assaysAnalytical Biochemistry, 1984